The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Chronic morphine treatment inhibits oxytocin synthesis in rats
Abstract
The changes of oxytocin content and mRNA expression in some nuclei were investigated in morphine-dependent rats using radioimmunoassay (RIA) and in situ hybridization (ISH). After chronic administration of morphine, the oxytocin content in supraoptic nucleus (SON) and nucleus accumbens (NAc) decreased, and increased in the ventral tegment area (VTA) and locus coeruleus (LC), but did not change in other nuclei including the paraventricular nucleus (PVN), lateral septum (SEPTUM), raphe magnus nucleus (NRM) and periaquaductal gray (PAG). In morphine-L dependent rats, naloxone increased the levels of oxytocin in SON and PVN, but decreased that in LC. ISH first showed that chronic morphine treatment inhibited the oxytocin synthesis in SON but not in PVN. The present study demonstrates that chronic morphine treatment alters the brain oxytocin system, suggesting that oxytocin might contribute to the behavioral and neuroendocrine responses to morphine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The chronic administration of morphine, a prototypical μ-opioid receptor agonist, also influences both the synthesis and secretion of OT (25).”
From Oxytocin under opioid antagonism leads to supralinear enhancement of social attention (2017) · cites this paper as [25]
Citations
Cites
Isolated removal of hypothalamic or other brain nuclei of the rat
Palkovits, M. (1973) · Brain Research · doi:10.1016/0006-8993(73)90290-4 · Cited by 1,431
Pittman, Q. J., Hatton, J. D., & Bloom, F. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5527 · Cited by 94
Wakerley, J. B., Noble, R., & Clarke, G. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90081-7 · Cited by 83
Opioid tolerance and dependence in the magnocellular oxytocin system: a physiological mechanism?
Ja, R., Leng, G., & Bicknell, R. (1995) · Experimental Physiology · doi:10.1113/expphysiol.1995.sp003850 · Cited by 75
Russell, J., Neumann, I. D., & Landgraf, R. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01024.1992 · Cited by 61
Inhibition of Oxytocin Release by Morphine and Its Analogs
Haldar, J., & Sawyer, W. H. (1978) · Experimental Biology and Medicine · doi:10.3181/00379727-157-40080 · Cited by 61
Rayner, V. C., Robinson, I. C., & Russell, J. A. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp016964 · Cited by 58
Pumford, K. M., Leng, G., & Russell, J. A. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018717 · Cited by 51
Evidence for a direct inhibitory effect of morphine on the secretion of posterior pituitary hormones
Lutz‐Bucher, B., & Koch, B. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90470-7 · Cited by 50
Oxytocin diminishes heroin tolerance in mice
Kov�cs, G. L., Faludi, M., & Telegdy, G. (1985) · Psychopharmacology · doi:10.1007/bf00432233 · Cited by 39
Research works printed but not linked: 1
- 1992, Neurosci Lett, 489, 283
Cited by
Sorted by citations
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
Breaking the loop: Oxytocin as a potential treatment for drug addiction
McGregor, I. S., & Bowen, M. T. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.001 · Cited by 268
McGregor, I. S., Callaghan, P. D., & Hunt, G. E. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.132 · Cited by 171
Ca2+-independent but voltage-dependent secretion in mammalian dorsal root ganglion neurons
Zhang, C., & Zhou, Z. (2002) · Nature Neuroscience · doi:10.1038/nn845 · Cited by 146
Zanos, P., Georgiou, P., Wright, S. R., Hourani, S. M., Kitchen, I., Winsky-Sommerer, R., & Bailey, A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.285 · Cited by 133
Oxytocin reduces alcohol cue-reactivity in alcohol-dependent rats and humans
Hansson, A. C., Koopmann, A., Uhrig, S., Bühler, S., Domi, E., Kiessling, E., Ciccocioppo, R., Froemke, R. C., Grinevich, V., Kiefer, F., et al. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.257 · Cited by 109
Oxytocin for the treatment of drug and alcohol use disorders
Lee, M. R., & Weerts, E. M. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000258 · Cited by 105
Yuen, K. W., Garner, J. P., Carson, D. S., Keller, J., Lembke, A., Hyde, S. A., Kenna, H. A., Tennakoon, L., Schatzberg, A. F., & Parker, K. J. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.12.012 · Cited by 99
Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date
Lee, M. R., Rohn, M. C. H., Tanda, G., & Leggio, L. (2016) · CNS Drugs · doi:10.1007/s40263-016-0313-z · Cited by 102
Slattery, D. A., & Neumann, I. D. (2010) · Pharmaceuticals · doi:10.3390/ph3030702 · Cited by 94
Early adverse experience and substance addiction: Dopamine, oxytocin, and glucocorticoid pathways
Kim, S., Kwok, S., Mayes, L. C., Potenza, M. N., Rutherford, H. J. V., & Strathearn, L. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13140 · Cited by 85
Rebalancing the Addicted Brain: Oxytocin Interference with the Neural Substrates of Addiction
Bowen, M. T., & Neumann, I. D. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.10.003 · Cited by 88
Vaccarino, A. L., & Kastin, A. J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00566-6 · Cited by 72
The role of oxytocin in alcohol and drug abuse
King, C. E., Gano, A., & Becker, H. C. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146761 · Cited by 69
Oxytocin and opioid addiction revisited: old drug, new applications
Zanos, P., Georgiou, P., Weber, C. D., Robinson, F., Kouimtsidis, C., Niforooshan, R., & Bailey, A. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13757 · Cited by 54
Oxytocin under opioid antagonism leads to supralinear enhancement of social attention
Dal Monte, O., Piva, M., Anderson, K. M., Tringides, M., Holmes, A. J., & Chang, S. W. C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702725114 · Cited by 55
Moeini, M., Omidi, A., Sehat, M., & Banafshe, H. R. (2019) · European Addiction Research · doi:10.1159/000496194 · Cited by 52
Butovsky, E., Juknat, A., Elbaz, J., Shabat-Simon, M., Eilam, R., Zangen, A., Altstein, M., & Vogel, Z. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.01.008 · Cited by 52
Opioid addiction: who are your real friends?
Eitan, S., Emery, M. A., Bates, M. L. S., & Horrax, C. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.017 · Cited by 42
Cid-Jofré, V., Moreno, M., Reyes-Parada, M. I., & Renard, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112077 · Cited by 40
Baracz, S. J., Everett, N. A., & Cornish, J. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136132 · Cited by 39
Nieuwenhuijzen, P. S. V., Long, L. E., Hunt, G. E., Arnold, J. C., & McGregor, I. S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1986-5 · Cited by 31
Oxytocin signaling in the treatment of drug addiction: Therapeutic opportunities and challenges
Che, X., Cai, J., Liu, Y., Xu, T., Yang, J., & Wu, C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107820 · Cited by 28
Mothering under the influence: how perinatal drugs of abuse alter the mother-infant interaction
Brancato, A., & Cannizzaro, C. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0052 · Cited by 28
Oxytocin mediates the inhibitory action of acute lithium on the morphine dependence in rats
You, Z. D., Li, J. H., Song, C. Y., Lu, C. L., & He, C. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(01)00272-3 · Cited by 23
Self-citationSeeber, B., Böttcher, B., D’Costa, E., & Wildt, L. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.07.001 · Cited by 24
Harder, H. J., Searles, C. T., Vogt, M. E., & Murphy, A. Z. (2023) · Hormones and Behavior · doi:10.1016/j.yhbeh.2023.105384 · Cited by 16
Oxytocin and the social facilitation of placebo effects
Itskovich, E., Bowling, D. L., Garner, J. P., & Parker, K. J. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01515-9 · Cited by 17
Reduced sodium appetite and increased oxytocin gene expression in mutant mice lacking β-endorphin
Franchini, L. F., Rubinstein, M., & Vivas, L. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00485-8 · Cited by 15
Opioids and the hormone oxytocin
Kovatsi, L., & Nikolaou, K. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.05.003 · Cited by 9
Nett, K. E., & LaLumiere, R. T. (2022) · Behavioral Neuroscience · doi:10.1037/bne0000544 · Cited by 8
Ponzoni, L., Braida, D., Bondiolotti, G., & Sala, M. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00146 · Cited by 9
Chronic morphine treatment inhibits oxytocin release from the supraoptic nucleus slices of rats
Li, J., You, Z.-D., Chen, Z.-Y., Song, C.-Y., & Lu, C.-L. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01540-3 · Cited by 9
Self-citationLack of neuropeptide Y attenuates the somatic signs of opiate withdrawal
Olson, V. G., Griner, N. B., Heusner, C. L., & Palmiter, R. D. (2006) · Synapse · doi:10.1002/syn.20328 · Cited by 8
Garland, E. L., & Jinpa, T. (2024) · Behaviour Research and Therapy · doi:10.1016/j.brat.2024.104494 · Cited by 6
Wang, J., & Zou, Z. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1072896 · Cited by 6
McGregor, I. S., & Bowen, M. T. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139017855.018 · Cited by 4
Oxytocin and opioid antagonists: A dual approach to improving social behavior
Monte, O. D., Gangopadhyay, P., Putnam, P. T., & Chang, S. W. C. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15376 · Cited by 3
Serum Oxytocin Level Among Male Patients With Opioid Dependence and Its Relation to Craving
Mobasher, M. W., Fathy, H., Soliman, A., El-Hanafi, H., & El-Makawi, S. M. (2020) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0000000000000231 · Cited by 3
El-Makawi, S. M., Mobasher, M. W., Eid, H., Soliman, A., El-Hanafi, H., Adel, S., & Mahfouz, N. A. (2021) · Egyptian Journal of Psychiatry · doi:10.4103/ejpsy.ejpsy_44_20 · Cited by 2
Oxytocin in rat nucleus raphe magnus influences pain modulation
Pan, Y.-J., Yin, Z., Yang, J., Zhao, Y., Yan, X., Qiu, P., & Wang, D. (2012) · World Journal of Neuroscience · doi:10.4236/wjns.2012.22017 · Cited by 1
Effects of Social-Interaction on Reward Sensitivity in Adolescent Mice
Cole, S. L. (2012) · OakTrust (Texas A&M University Libraries)
Endocrinological Effects of Drugs of Abuse
Reed, B., & Kreek, M. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00087-0
Pharmacological Characterisation of Novel Oxytocin and Vasopressin Receptor Ligands
Gulliver, D. W. (2021) · The Sydney eScholarship Repository (The University of Sydney)
Opioid quantification via microsampling techniques to assess opioid use in human laboratory studies
Fariha, R., Rothkopf, E., Haass‐Koffler, C. L., & Tripathi, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-99130-5
Metadata
- Authors
- You, Z.-D., Li, J.-H., Song, C.-Y., Wang, C.-H., & Lu, C.-L.
- Affiliations
- Second Military Medical University (CN)
- Venue
- Neuroreport
- Published
- 2000-09
- Volume
- 11
- Issue
- 14
- Pages
- 3113-3116
- ISSN
- 0959-4965 (ISSN-L)
- OpenAlex
- W1985852293
- Cited by
- 45
- References
- 14
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 3 · 2017: 7 · 2016: 4 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroreport (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- chronic morphine administration, morphine dependence, supraoptic nucleus, paraventricular nucleus, nucleus accumbens, ventral tegmental area, locus coeruleus, naloxone
- MeSH terms
- Animals, Brain, Drug Administration Schedule, Hypothalamo-Hypophyseal System, Male, Morphine, Morphine Dependence, Naloxone, Neurons, Oxytocin, RNA, Messenger, Substance Withdrawal Syndrome, Supraoptic Nucleus, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review